<!DOCTYPE html>
<html lang="es">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="./css/min.css">
    <link rel="stylesheet" href="./css/medium.css">
    <link rel="stylesheet" href="./css/desktop.css">
    <title>Examen 1</title>
</head>

<body>
    <div class="barrita">
        <ul>
            <li class="menu-device-mobile"> Menu</li>
            <li class="logo"><img src="./img/logo_2.svg" alt="logo empresa"></li>
            <div class="menu-display">
                <li class="logo-medium">
                    <h5 class="logo-medium-title">Safety observe</h5>
                </li>
                <li class="menu-medium">Home</li>
                <li class="menu-medium">Plans</li>
                <li class="menu-medium">News</li>
                <li class="menu-medium">Assistance</li>
                <li class="login"><a href="#">Login</a></li>
                <li class="alert"><button>sign up for alert</button></li>
            </div>
            <li class="carrito"><img src="./img/carrito.png" alt="carro"></li>
        </ul>
    </div>
    <div class="cabezera">
        <h2 class="cabezera-title"> Regulatory Intelligence, straight to your mailbox</h2>
        <p class="cabezera-body">Stay on top of Human Pharmacovigilance requirements with our monthly Regulatory
            Intelligence Reports</p>
        <ul class="cabezera-botones">
            <li><button class="cabezera-botones-blue">sign up for alert</button></li>
            <li><button class="cabezera-botones-white">View Plans</button></li>
        </ul>
    </div>
    <div class="linea-2">
        <ul class="menu-linea-2">
            <li class="menu-linea-2-options">Monthly reports</li>
            <li class="menu-linea-2-options">Subscripion plans</li>
            <li class="menu-linea-2-options">Over 70 Pharma & Biotech clients</li>
            <li class="menu-linea-2-options">Over 3,000 users</li>
        </ul>
    </div>
    <div class="sales-new">
        <div class="portada-sales-new">
            <img src="./img/coverweb_187.jpg" alt="imagen libro reciente" class="img-sales-new">
        </div>
        <div class="obsersa-sales-new">
            <ul>
                <li class="obser-part-new">Latest report - March 2022 </li>
                <li class="obser-part-new-title">
                    <h3>Safety Observer 187</h3>
                </li>
                <li class="obser-part-new-body">
                    <p>
                        The EMA has revised its RMP guidance for COVID-19 vaccines with updated requirements for Summary
                        Safety Reports.
                    </p>
                </li>
                <li class="obser-part-new-date-titule">Released:</li>
                <li class="obser-part-new-date-date"> 09-Mar-2022</li>
                <li class="obser-part-new-pages-titule">Pages:</li>
                <li class="obser-part-new-pages-number">29</li>
                <li>
                    <button class="obser-part-new-button-blue">Buy - 72 Euros</button>
                </li>
                <li>
                    <button class="obser-part-new-button-white">Hightlights</button>
                </li>
            </ul>
        </div>
        <div class="past-port-table">
            <h3 class="Past-report-1-titule">Past Report</h3>
            <div class="Past-report-1">
                <div class="portada-past-1">
                    <img src="./img/coverweb_186.jpg" alt="imagen libro portada" class="img-past-1">
                </div>
                <div class="obsersa-past-1">
                    <ul>
                        <li class="obser-past-1-date">February 2022</li>
                        <li class="obser-past-1-title">
                            <h3>Safety Observer 186</h3>
                        </li>
                        <li class="obser-past-1-body">
                            <p>
                                The new EU Clinical Trial Regulation became applicable as the CTIS went live on
                                31-Jan-2022.
                            </p>
                        </li>
                        <li class="obser-past-1-button-blue">
                            <button>Buy-72 Euros</button>
                        </li>
                        <li class="obser-past-1-button-white">
                            <button>Hightlights</button>
                        </li>
                    </ul>
                </div>
            </div>

            <div class="Past-report-2">
                <div class="portada-past-2">
                    <img src="./img/coverweb_185.jpg" alt="imagen libro portada" class="img-past-2">
                </div>

                <div class="obsersa-past-2">
                    <ul>
                        <li class="obser-past-2-date">
                            January 2022
                        </li>
                        <li class="obser-past-2-title">
                            <h3>Safety Observer 185</h3>
                        </li>
                        <li class="obser-past-2-body">
                            <p>
                                Both the US FDA and the MHRA have published new guidance to promote the use of RWD in
                                clinical trials.
                            </p>
                        </li>
                        <li class="obser-past-2-button-blue">
                            <button>Buy-72 Euros</button>
                        </li>
                        <li class="obser-past-2-button-white">
                            <button>Hightlights</button>
                        </li>
                    </ul>
                </div>
            </div>

            <div class="Past-report-3">
                <div class="portada-past-3">
                    <img src="./img/coverweb_184.jpg" alt="imagen libro portada" class="img-past-3">
                </div>

                <div class="obsersa-past-3">
                    <ul>
                        <li class="obser-past-3-date">
                            December 2021
                        </li>
                        <li class="obser-past-3-title">
                            <h3>Safety Observer 184</h3>
                        </li>
                        <li class="obser-past-3-body">
                            <p>
                                The FDA has published a new draft guidance that provides considerations for the use of
                                registries.
                            </p>
                        </li>
                        <li class="obser-past-3-button-blue">
                            <button>Buy-72 Euros</button>
                        </li>
                        <li class="obser-past-3-button-white">
                            <button>Hightlights</button>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        <div class="sub-plans">

            <div class="sub-plans-left">
                <h4 class="sub-plans-left-title">3 month plan</h4>
                <p class="sub-plans-left-body">
                    Lorem ipsum dolor sit amet consectetur adipisicing elit. Iste, laboriosam!
                </p>
                <h5 class="sub-plans-left-cost">Start at 180 Eur</h5>
                <ul class="sub-plans-left-benefit">
                    <li>3 Regullatory inteligence</li>
                    <li>Volume price avaible</li>
                    <li>16% OFF</li>
                </ul>
                <ul class="sub-plans-left-button">
                    <li>
                        <button class="sub-plans-left-button-blue">Buy 3-Month Plan</button>
                    </li>
                    <li>
                        <button class="sub-plans-left-button-white">More info</button>
                    </li>
                </ul>
            </div>

            <div class="sub-plans-right">
                <h4 class="sub-plans-right-title">1 year plan</h4>
                <p class="sub-plans-right-body">
                    Lorem ipsum dolor sit amet consectetur adipisicing elit. Iste, laboriosam!
                </p>
                <h5 class="sub-plans-right-cost">Start at 600 Eur</h5>
                <ul class="sub-plans-right-benefit">
                    <li>11 Regullatory inteligence</li>
                    <li>Volume price avaible</li>
                    <li>24% OFF</li>
                </ul>
                <ul class="sub-plans-right-button">
                    <li>
                        <button class="sub-plans-right-button-blue">Buy 1-Year Plan</button>
                    </li>
                    <li>
                        <button class="sub-plans-right-button-white">More info</button>
                    </li>
                </ul>
            </div>

        </div>

        <div class="pre-footer">
            <div class="pre-footer-left-title">
                <p>Supporting the global Pharmacovigilance community since 2005</p>
            </div>
            <div class="pre-footer-left">
                <ul>
                    <li class="pre-footer-left-center">
                        <p class="container-left-center">
                            We are proud to serve pharmacovigilance professionals in more than 100 organisations across
                            the world, including major pharma corporations, small biotech, service providers, and public
                            hospitals.
                        </p>
                    </li>
                    <li class="pre-footer-left-button">
                        <button>About US</button>
                    </li>
                </ul>
            </div>
        </div>

        <div class="pata">
            <footer>
                <ul>
                    <li class="pata-logo"><img src="./img/logo_2.svg" alt="Logo empresa"></li>
                    <li class="pata-copyright">
                        <h4>Safety Observer, 2005—2021</h4>
                    </li>
                    <li class="pata-url-legal"><a href="#">Legal</a></li>
                    <li class="pata-social-media"><a href="#">Facebook</a></li>
                    <li class="pata-social-media"><a href="#">Linkedin</a></li>
                </ul>
            </footer>
        </div>

</body>

</html>